Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Are Neuroendocrine Cancers Rare?

Are Neuroendocrine Cancers Rare?

Today is Rare Disease Day. Assumed rare, Neuroendocrine Cancer is now England's 10th most prevalent Cancer, with a continually rising incidence – that has already seen a 371% increase since 1995.   Neuroendocrine Cancer UK's Catherine Bouvier cuts through the...

read more
One Cancer Voice – Petition to the Prime Minister

One Cancer Voice – Petition to the Prime Minister

One Cancer Voice - Petition to the Prime Minister to demand the UK Government keeps its commitment to transform cancer care and services. In a speech at the Francis Crick Institute on World Cancer Day 2022 (4 February), the then Health and Social Care Secretary, Rt...

read more
Dr Garan Jones – Research Grant Winner

Dr Garan Jones – Research Grant Winner

Winner of Neuroendocrine Cancer UK's £30,000 grant for research Dr Garan Jones, the University of Exeter - "Our research project is titled “Determining the role of alternate splicing in the development of Small Intestine Neuroendocrine tumours (SI-NET)”. Alternative...

read more